Expression of HOXC8 is inversely related to the progression and metastasis of pancreatic ductal adenocarcinoma

British Journal of Cancer

Volumn 105, Issue 2, 2011, Pages 288-295

  Adwan, H ^a   Zhivkova Galunska, M ^a   Georges, R ^a   Eyol, E ^a   Kleeff, J ^b   Giese, N A ^c   Friess, H ^b   Bergmann, F ^c   Berger, M R ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

HOXC8; liver metastasis; osteonectin; osteopontin; pancreatic ductal adenocarcinoma

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXC8; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE PANCREATITIS; CANCER CELL CULTURE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER METASTASIS; MALE; NONHUMAN; NUDE RAT; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; RATS; RATS, NUDE; RNA, SMALL INTERFERING; XENOGRAFT MODEL ANTITUMOR ASSAYS; YOUNG ADULT;

EID: 79960222639     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.217     Document Type: Article

References (39)

1. Abate-Shen C (2002) Deregulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer 2(10): 777-785 (Pubitemid 37328912)
2. Adwan H, Bauerle TJ, Berger MR (2004) Downregulation of osteopontin and bone sialoprotein II is related to reduced colony formation and metastasis formation of MDA-MB-231 human breast cancer cells. Cancer Gene Ther 11(2): 109-120 (Pubitemid 38141773)
3. Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, Szabo M, Cantor A, Coppola D, Yeatman TJ (2002) Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94(7): 513-521 (Pubitemid 34411290)
4. Axlund SD, Lambert JR, Nordeen SK (2010) HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes. Mol Cancer Res 8(12): 1643-1655
5. Belting HG, Shashikant CS, Ruddle FH (1998) Multiple phases of expression and regulation of mouse Hoxc8 during early embryogenesis. J Exp Zool 282(1-2): 196-222 (Pubitemid 28395520)
6. Brekken RA, Sage EH (2001) SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol 19(8): 816-827
7. Brown LF, Papadopoulos-Sergiou A, Berse B, Manseau EJ, Tognazzi K, Perruzzi CA, Dvorak HF, Senger DR (1994) Osteopontin expression and distribution in human carcinomas. Am J Pathol 145(3): 610-623 (Pubitemid 24285968)
8. Chen KN, Gu ZD, Ke Y, Li JY, Shi XT, Xu GW (2005) Expression of 11 HOX genes is deregulated in esophageal squamous cell carcinoma. Clin Cancer Res 11(3): 1044-1049 (Pubitemid 40175752)
9. Cillo C, Cantile M, Faiella A, Boncinelli E (2001) Homeobox genes in normal and malignant cells. J Cell Physiol 188(2): 161-169 (Pubitemid 32622906)
10. Fedarko NS, Jain A, Karadag A, Van Eman MR, Fisher LW (2001) Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res 7(12): 4060-4066 (Pubitemid 34044628)
11. Fisher LW, Torchia DA, Fohr B, Young MF, Fedarko NS (2001) Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem Biophys Res Commun 280(2): 460-465 (Pubitemid 32912812)
12. Franke K, Carl-McGrath S, Rohl FW, Lendeckel U, Ebert MP, Tanzer M, Pross M, Rocken C (2009) Differential expression of SPARC in intestinal-type gastric cancer correlates with tumor progression and nodal spread. Transl Oncol 2(4): 310-320
13. Giachelli CM, Steitz S (2000) Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol 19(7): 615-622
14. Graham JD, Balleine RL, Milliken JS, Bilous AM, Clarke CL (1997) Expression of osteonectin mRNA in human breast tumours is inversely correlated with oestrogen receptor content. Eur J Cancer 33(10): 1654-1660 (Pubitemid 28123490)
15. Guo J, Kleeff J, Li J, Ding J, Hammer J, Zhao Y, Giese T, Korc M, Buchler MW, Friess H (2004) Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma. Oncogene 23(1): 71-81 (Pubitemid 38142241)
16. Guweidhi A, Kleeff J, Adwan H, Giese NA, Wente MN, Giese T, Buchler MW, Berger MR, Friess H (2005) Osteonectin influences growth and invasion of pancreatic cancer cells. Ann Surg 242(2): 224-234 (Pubitemid 41033439)
17. Hung YC, Ueda M, Terai Y, Kumagai K, Ueki K, Kanda K, Yamaguchi H, Akise D, Ueki M (2003) Homeobox gene expression and mutation in cervical carcinoma cells. Cancer Sci 94(5): 437-441 (Pubitemid 36790476)
18. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ (2005) Cancer statistics, 2005. CA Cancer J Clin 55(1): 10-30 (Pubitemid 40310185)
19. Juan AH, Lei H, Bhargava P, Lebrun M, Ruddle FH (2006) Multiple roles of hoxc8 in skeletal development. Ann N Y Acad Sci 1068: 87-94 (Pubitemid 43824139)
20. Kolb A, Kleeff J, Guweidhi A, Esposito I, Giese NA, Adwan H, Giese T, Buchler MW, Berger MR, Friess H (2005) Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions. Cancer Biol Ther 4(7): 740-746 (Pubitemid 41351173)
21. Lane TF, Sage EH (1994) The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J 8(2): 163-173 (Pubitemid 24067139)
22. Le MH, Lallemand Y, Brulet P (1992) Homeosis in the mouse induced by a null mutation in the Hox-3.1 gene. Cell 69(2): 251-264
23. Lei H, Wang H, Juan AH, Ruddle FH (2005) The identification of Hoxc8 target genes. Proc Natl Acad Sci USA 102(7): 2420-2424 (Pubitemid 40279391)
24. Li D, Xie K, Wolff R, Abbruzzese JL (2004) Pancreatic cancer. Lancet 363(9414): 1049-1057 (Pubitemid 38410779)
25. Miller GJ, Miller HL, van BA, Lambert JR, Werahera PN, Schirripa O, Lucia MS, Nordeen SK (2003) Aberrant HOXC expression accompanies the malignant phenotype in human prostate. Cancer Res 63(18): 5879-5888 (Pubitemid 37187488)
26. Podhajcer OL, Benedetti L, Girotti MR, Prada F, Salvatierra E, Llera AS (2008) The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host. Cancer Metastasis Rev 27(3): 523-537
27. Porte H, Chastre E, Prevot S, Nordlinger B, Empereur S, Basset P, Chambon P, Gespach C (1995) Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes. Int J Cancer 64(1): 70-75
28. Porter PL, Sage EH, Lane TF, Funk SE, Gown AM (1995) Distribution of SPARC in normal and neoplastic human tissue. J Histochem Cytochem 43(8): 791-800
29. Roy S, Sen S (2005) Homology modeling based solution structure of Hoxc8-DNA complex: role of context bases outside TAAT stretch. J Biomol Struct Dyn 22(6): 707-718 (Pubitemid 40696198)
30. Sato N, Fukushima N, Maehara N, Matsubayashi H, Koopmann J, Su GH, Hruban RH, Goggins M (2003) SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions. Oncogene 22(32): 5021-5030 (Pubitemid 37026400)
31. Shen ZJ, Kim SK, Jun DY, Park W, Kim YH, Malter JS, Moon BJ (2007) Antisense targeting of TGF-beta1 augments BMP-induced upregulation of osteopontin, type I collagen and Cbfa1 in human Saos-2 cells. Exp Cell Res 313(7): 1415-1425 (Pubitemid 46507441)
32. Shimamoto T, Tang Y, Naot Y, Nardi M, Brulet P, Bieberich CJ, Takeshita K (1999) Hematopoietic progenitor cell abnormalities in Hoxc-8 null mutant mice. J Exp Zool 283(2): 186-193 (Pubitemid 29053736)
33. Thickett C, Morgan R (2002) Hoxc-8 expression shows left-right asymmetry in the posterior lateral plate mesoderm. Gene Expr Patterns 2(1-2): 5-6 (Pubitemid 36356005)
34. Thomas R, True LD, Bassuk JA, Lange PH, Vessella RL (2000) Differential expression of osteonectin/SPARC during human prostate cancer progression. Clin Cancer Res 6(3): 1140-1149 (Pubitemid 30159378)
35. Waltregny D, Alami Y, Clausse N, de LJ, Castronovo V (2002) Over-expression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation. Prostate 50(3): 162-169 (Pubitemid 34137443)
36. Wan M, Shi X, Feng X, Cao X (2001) Transcriptional mechanisms of bone morphogenetic protein-induced osteoprotegrin gene expression. J Biol Chem 276(13): 10119-10125
37. Yang E, Kang HJ, Koh KH, Rhee H, Kim NK, Kim H (2007) Frequent inactivation of SPARC by promoter hypermethylation in colon cancers. Int J Cancer 121(3): 567-575 (Pubitemid 46986490)
38. Yueh YG, Gardner DP, Kappen C (1998) Evidence for regulation of cartilage differentiation by the homeobox gene Hoxc-8. Proc Natl Acad Sci USA 95(17): 9956-9961 (Pubitemid 28415276)
39. Zhivkova-Galunska M, Adwan H, Eyol E, Kleeff J, Kolb A, Bergmann F, Berger MR (2010) Osteopontin but not osteonectin favors the metastatic growth of pancreatic cancer cell lines. Cancer Biol Ther 10(1): 54-64